#Zip code for 4d molecular therapeutics registration#
#Zip code for 4d molecular therapeutics zip#

Prior to this offering, there has been no public market for our common stock.

We are offering shares of our common stock.

Public offering of shares of common stock of 4D Molecular Therapeutics, Inc. Subject to Completion, Dated November, 2020 Securities in any jurisdiction where the offer or sale is not permitted. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these

#Zip code for 4d molecular therapeutics registration#

We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. The information contained in this preliminary prospectus is not complete and may be changed. Shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall becomeĮffective on such date as the Commission, acting pursuant to said Section 8(a), may determine. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant Includes shares that the underwriters have the option to purchase additional shares.Ĭalculated pursuant to Rule 457(o) based on an estimate of the proposed maximum offering price. ☐Ĭommon Stock, $0.0001 par value per shareĮstimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under Period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition See the definitions of large accelerated filer, accelerated filer, smaller reportingĬompany and emerging growth company in Rule 12b-2 of the Exchange Act. Indicate by check mark whether the registrant is a large acceleratedįiler, an accelerated filer, a non-accelerated filer, or a smaller reporting company. Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same If this Form is a post-effective amendment filed pursuant to If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the SecuritiesĪdditional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same

#Zip code for 4d molecular therapeutics zip#

(Name, address, including zip code, and telephone number, including area code, of agent for service)Īpproximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement. (Address, including zip code, and telephone number, including area code, of Registrants principal As filed with the Securities and Exchange Commission on November 17, 2020.